Apellis Pharmaceuticals | DEF 14A: Definitive information statements
Apr 27 04:35
Apellis Pharmaceuticals | DEFA14A: Others
Apr 27 04:18
Apellis Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 27 20:40
Apellis Pharmaceuticals | 8-K: Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 27 20:35
Apellis Pharmaceuticals | 8-K: Current report
Jan 22 13:00
Apellis Pharmaceuticals | 8-K: Current report
Jan 8 13:00
Apellis Pharmaceuticals | 8-K: Current report
Dec 14, 2023 20:04
Apellis Pharmaceuticals | 8-K: Current report
Dec 1, 2023 21:37
Apellis Pharmaceuticals | 8-K: Current report
Nov 1, 2023 19:59
Apellis Pharmaceuticals | 8-K: Current report
Oct 5, 2023 19:15
Apellis Pharmaceuticals | 8-K: Current report
Aug 29, 2023 19:05
Apellis Pharmaceuticals | 8-K: Current report
Aug 23, 2023 04:49
Apellis Pharmaceuticals | 8-K: Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results
Jul 31, 2023 20:03
Apellis Pharmaceuticals | 8-K: Current report
Jul 18, 2023 04:14
Apellis Pharmaceuticals | 8-K: Current report
Jun 2, 2023 04:10
Apellis Pharmaceuticals | DEFA14A: Others
Apr 21, 2023 21:03
Apellis Pharmaceuticals | DEF 14A: Definitive proxy statements
Apr 21, 2023 21:00
Apellis Pharmaceuticals | 8-K: Current report
Mar 16, 2023 04:37
Apellis Pharmaceuticals | 8-K: Current report
Feb 24, 2023 22:27
Apellis Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Feb 22, 2023 20:17
No Data
No Data